Find out more about investing in ET-traps by reading our overview document.

ET-traps Limited Intellectual Property portfolio comprises of patent covering formulations of ET-traps. The pharmaceutical company's filing strategy has preserved substantial scope for further broadening of method claims to encompass other therapeutic uses and extend patent life.

Should you be interested in discussing potential investment opportunities, we would of course be delighted to hear from you. Please contact us by email in the first instance.